Update on biology and management of mesothelioma

Rachelle Asciak, Vineeth George, Najiib M. Rahman

Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020

Journal Issue: March

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rachelle Asciak, Vineeth George, Najiib M. Rahman. Update on biology and management of mesothelioma. Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Contemporary management of malignant mesothelioma Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases Year: 2004
Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014
Keynote lecture: Introduction: Treatment options and tumour biology of malignant pleural mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011
Malignant mesothelioma: new treatment advances, including targeted therapies Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care Year: 2021
Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease” Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016
Update on the management of bronchiectasis Source: International Congress 2017 – Non-CF bronchiectasis in children Year: 2017
New molecular-directed therapies for mesothelioma: have there been any advances? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014
Approaches to radiological staging of mesothelioma relating to modern treatment modalities Source: Virtual Congress 2021 – Thoracic oncology Year: 2021
Milestones in the management of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Malignant pleural mesothelioma: new treatments, new hopes? Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017 Year: 2017
Advances in the therapeutical management of IPF Source: Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis Year: 2012
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment Source: Eur Respir Rev 2016; 25: 472-486 Year: 2016
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic Source: Eur Respir Rev 2015; 24: 115-131 Year: 2015
Translational therapeutics in pleural malignancies Source: ERS Skills course - Medical thoracoscopy Year: 2017
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020
Malignant pleural mesothelioma: Current status and future projections in Turkey Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Update on management of ARDS Source: Annual Congress 2013 –ME10 Update on management of ARDS Year: 2013